Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis.
Show reference:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext
